Coleman, Craig I.
Costa, Olivia S.
Brescia, Christopher W.
Vardar, Burcu
Abdelgawwad, Khaled
Sood, Nitesh
Funding for this research was provided by:
Bayer AG
Article History
Received: 11 January 2021
Accepted: 19 February 2021
First Online: 26 February 2021
Ethics approval and consent to participate
: The use of the provided OptumĀ® De-Identified EHR data was determined by the New England Institutional Review Board (IRB) to not constitute research involving human subjects and was therefore exempt from board oversight.
: Not applicable.
: CIC has received grant funding and consultancy fees from Janssen Scientific Affairs LLC, Titusville, NJ, Bayer AG, Berlin, Germany; Portola Pharmaceuticals, South San Francisco, CA; and speaker fees from Medscape Inc. BV and KA are employees of Bayer AG, Berlin, Germany. OSC, CWB, and NS have no conflicts of interest to disclose.